MX2019005682A - Metodos y dispositivos para la deteccion del virus de la hepatitis c. - Google Patents

Metodos y dispositivos para la deteccion del virus de la hepatitis c.

Info

Publication number
MX2019005682A
MX2019005682A MX2019005682A MX2019005682A MX2019005682A MX 2019005682 A MX2019005682 A MX 2019005682A MX 2019005682 A MX2019005682 A MX 2019005682A MX 2019005682 A MX2019005682 A MX 2019005682A MX 2019005682 A MX2019005682 A MX 2019005682A
Authority
MX
Mexico
Prior art keywords
methods
virus
devices
hcv
detecting hepatitis
Prior art date
Application number
MX2019005682A
Other languages
English (en)
Inventor
J Clarke Nigel
Rogers Amy
A Leake John
e baumann Russell
Original Assignee
Quest Diagnostics Invest Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quest Diagnostics Invest Llc filed Critical Quest Diagnostics Invest Llc
Publication of MX2019005682A publication Critical patent/MX2019005682A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente divulgación proporciona métodos rápidos y no invasivos para determinar si un paciente se beneficiará del tratamiento con agentes terapéuticos que inhiben al virus de la hepatitis C (VHC). Estos métodos se basan en detectar ARN de VHC y/o anticuerpos anti-VHC en muestras de fluidos biológicos secos de pequeño volumen, las cuales son recolectadas utilizando un dispositivo volumétrico absortivo de micromuestreo. Los kits para usarse en la práctica de los métodos también son proporcionados.
MX2019005682A 2016-11-15 2017-11-13 Metodos y dispositivos para la deteccion del virus de la hepatitis c. MX2019005682A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662422321P 2016-11-15 2016-11-15
US201662425263P 2016-11-22 2016-11-22
PCT/US2017/061303 WO2018093721A2 (en) 2016-11-15 2017-11-13 Methods and devices for detecting hepatitis c virus

Publications (1)

Publication Number Publication Date
MX2019005682A true MX2019005682A (es) 2019-10-30

Family

ID=62107725

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019005682A MX2019005682A (es) 2016-11-15 2017-11-13 Metodos y dispositivos para la deteccion del virus de la hepatitis c.

Country Status (8)

Country Link
US (2) US20180136211A1 (es)
EP (1) EP3541960A4 (es)
JP (2) JP2020511956A (es)
CN (1) CN110168111A (es)
BR (1) BR112019009798A2 (es)
CA (1) CA3044031A1 (es)
MX (1) MX2019005682A (es)
WO (1) WO2018093721A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018093723A1 (en) 2016-11-15 2018-05-24 Quest Diagnostics Investments Llc Methods for detecting cystic fibrosis mutations using mitra tip extraction
WO2021216780A1 (en) * 2020-04-21 2021-10-28 Biomerica, Inc. Collection devices for biological samples and methods of use thereof
CN113679701B (zh) * 2020-05-18 2024-04-30 中国科学院上海药物研究所 邻苯三酚及其衍生物作为共价配体反应弹头的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7696329B2 (en) * 2006-06-23 2010-04-13 Florida State University Research Foundation, Inc. Immunoglobulin peptides against heated bovine blood
US20130116597A1 (en) * 2011-11-04 2013-05-09 Phenomenex, Inc. Method and apparatus for acquiring blood for testing

Also Published As

Publication number Publication date
EP3541960A2 (en) 2019-09-25
CN110168111A (zh) 2019-08-23
US20190276904A1 (en) 2019-09-12
EP3541960A4 (en) 2020-06-10
US20180136211A1 (en) 2018-05-17
JP2020511956A (ja) 2020-04-23
WO2018093721A3 (en) 2018-06-21
WO2018093721A2 (en) 2018-05-24
JP2022191225A (ja) 2022-12-27
CA3044031A1 (en) 2018-05-24
BR112019009798A2 (pt) 2019-08-06

Similar Documents

Publication Publication Date Title
WO2018126082A8 (en) Digital microfluidic devices and methods
IL258101A (en) Device and system for testing samples, especially blood, and methods for using them
SG11202002931VA (en) Portable molecular diagnostic device and methods for the detection of target viruses
MX2022014633A (es) Metodos para detectar norovirus.
HK1257999A1 (zh) 用於臨床應用的分析物收集、提取、濃縮和檢測的方法和裝置
MX2019005682A (es) Metodos y dispositivos para la deteccion del virus de la hepatitis c.
CA185723S (en) Medical device for processing biological samples
EA201992546A1 (ru) Средства на основе антител к cd33
DK3202324T3 (da) Medicinsk anordning til påvisning af mindst én analyt i en kropsvæske
MX2019005683A (es) Metodos para detectar mutaciones de adn mediante el uso de extraccion con puntas mitra.
BR112016017986A2 (pt) anticorpos isolados, ácido nucleico isolado, célula hospedeira, métodos de produção de um anticorpo, de tratamento do câncer, de tratamento de uma doença e de detecção de jagged1 humana em uma amostra biológica, imunoconjugado, formulação farmacêutica e uso do anticorpo
CL2011002524A1 (es) Compuestos derivados de 1,3-diazol-fenil-(etinil, etenil o ciclopropil)-fenil-1,3-diazol sustituidos, inhibidores ns5a; composicion farmaceutica que los comprende y su uso en tratamiento de la hepatitis c.
DK4233719T3 (da) Medicinsk anordning til påvisning af mindst én analyt i en kropsvæske
FR3016726B1 (fr) Dispositif pour l'irradiation d'echantillons dans le cœur ou en peripherie du cœur d'un reacteur
IL276971A (en) In vitro device and matrix for removing fibrinolytic proteins from biological fluids, methods and uses thereof
SG11202008891RA (en) Biological tissue analyzing device, biological tissue analyzing program, and biological tissue analyzing method
EA201691682A1 (ru) Способы анализирования редких циркулирующих в крови клеток
JP2017526916A5 (es)
MX2019005684A (es) Métodos para detectar mutaciones de fibrosis quística mediante el uso de extracción con puntas mitra.
MX2018011625A (es) Metodos para detectar bordetella.
SG11202110642VA (en) Method and device for measuring the fibrinogen concentration in blood samples.
WO2018026969A3 (en) Plazomicin antibodies and methods of use
RS64368B1 (sr) Postrojenje i postupak za tretman otpada, posebno otpada iz laboratorija za medicinsku analizu
PT2646825T (pt) Teste rápido para a determinação qualitativa e/ou quantitativa de anticorpos contra o vírus do papiloma humano contidos em fluido corporal, bem como dispositivo para a realização do teste rápido
EP4407047A3 (en) Molecular detection of enterovirus and parechovirus